ContraFect Announces Issuance of Composition of Matter
ContraFect Announces Issuance of Composition of Matter Patent for CF-370 by the United States Patent and Trademark Office May 03, 2021 07:30 ET | Source: ContraFect Corporation ContraFect Corporation Yonkers, New York, UNITED STATES YONKERS, N.Y., May 03, 2021 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-res...
Source: globenewswire.com